drugset / Trial / NCT06244290
Dentinal Hypersensitivity Reduction
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this clinical study is to assess the efficacy of a dentifrice containing stannous fluoride (Colgate-Palmolive Company, New York, NY, USA) as compared to a commercially-available potassium-based toothpaste (Sensodyne Extra Whitening Toothpaste, GlaxoSmithKline Co., UK) and a commercially available non-desensitizing toothpaste (Colgate Cavity Protection Toothpaste, Colgate-Palmolive Company, New York, NY, USA) in the reduction of dentinal hypersensitivity over a seven (7) day period.
Timeline
- Start
- 2020-09-28
- Primary completion
- 2020-10-21
- Completion
- 2020-10-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Colgate Fluoride (CDC) | Unknown | — | — |
| Comparator | Sensodyne Extra Whitening | Unknown | — | — |
| Comparator | stannous fluoride | Small molecule | — | — |